Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Acute Coronary Syndrome
Interventions
DRUG

YH14659

YH14659 capsule by oral

DRUG

clopidogrel & aspirin

clopidogrel tablet(75mg) + aspirin capsules(100mg) by oral

Trial Locations (1)

156-754

Yuhan Corporation, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT01657071 - Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter